Latest News in the pharma Industry

Policy & Regulation

Avedro Announces Receipt of Complete Response Letter from FDA for Corneal Cross-Linking NDA

Avedro Announces Receipt of Complete Response Letter from FDA for Corneal Cross-Linking NDA

1 Apr 2015

Read more 
EMA Validates Marketing Authorisation Application for Zinbryta (Daclizumab High-Yield Process) for Treatment of MS

EMA Validates Marketing Authorisation Application for Zinbryta (Daclizumab High-Yield Process) for Treatment of MS

30 Mar 2015

Read more 
Orexigen's Mysimba Approved in Europe for the Treatment of Obesity

Orexigen's Mysimba Approved in Europe for the Treatment of Obesity

30 Mar 2015

Read more 
BIO Urges Governor Herbert to Sign Bill That Ensures Patient Access to Interchangeable Biologic Medicines

BIO Urges Governor Herbert to Sign Bill That Ensures Patient Access to Interchangeable Biologic Medicines

18 Mar 2015

Read more 
Novartis receives EU Approval for Jakavi in Polycythemia Vera, First Targeted Therapy Approved for Patients with this Rare Blood Cancer?

Novartis receives EU Approval for Jakavi in Polycythemia Vera, First Targeted Therapy Approved for Patients with this Rare Blood Cancer?

17 Mar 2015

Read more 
Actavis Confirms Appeals Court Grants Injunction Pending Appeal Related to Generic Pulmicort Respules

Actavis Confirms Appeals Court Grants Injunction Pending Appeal Related to Generic Pulmicort Respules

13 Mar 2015

Read more 
FDA Approves First Therapy for High-Risk Neuroblastoma

FDA Approves First Therapy for High-Risk Neuroblastoma

11 Mar 2015

Read more 
Astellas Receives FDA Approval for Cresemba

Astellas Receives FDA Approval for Cresemba

9 Mar 2015

Read more 
New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2015

New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2015

6 Mar 2015

Read more 
FDA Approves Landmark Drug for Lung Cancer Patients

FDA Approves Landmark Drug for Lung Cancer Patients

5 Mar 2015

Read more 
Actavis Receives Approval from the European Commission for Xydalba

Actavis Receives Approval from the European Commission for Xydalba

3 Mar 2015

Read more 
Actavis Receives FDA Approval for Avycaz

Actavis Receives FDA Approval for Avycaz

2 Mar 2015

Read more